Preclinical sporadic Alzheimer's disease: Target for personalized diagnosis and preventive intervention

Metabolism: Clinical and Experimental

Volumn 62, Issue SUPPL.1, 2013, Pages

  Vanitallie, Theodore B ^a  

^a Columbia University ^*  (United States)

Author keywords

Apolipoprotein E 4; Cerebral metabolic rate of glucose; Fluorodeoxyglucose positron emission tomography; Neuroimaging biomarkers; Personalized medicine

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; FLUORODEOXYGLUCOSE;

ALZHEIMER DISEASE; BRAIN FUNCTION; CONTACT SPORT; DISEASE COURSE; FAMILY HISTORY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; TRAUMATIC BRAIN INJURY;

EID: 84870566969     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.08.024     Document Type: Article

References (33)

1. D.S. Knopman, C.R. Jack Jr., and H.J. Wiste Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease Neurology 78 2012 1576 1582
2. H. Braak, and E. Braak Staging of Alzheimer's disease-related neurofibrillary changes Neurobiol Aging 16 1995 271 278
3. Alzheimer Association report 2011: Alzheimer's disease facts and figures Alzheimers Dement 7 2011 208 244
4. J. Raber, Y. Huang, and J.W. Ashford ApoE genotype accounts for the vast majority of risk and AD pathology Neurobiol Aging 25 2004 641 650
5. C.Y. Lee, W. Tse, J.D. Smith, and G.E. Landreth Apolipoprotein E promotes β-amyloid trafficking and degradation by modulating microglial cholesterol levels J Biol Chem 287 2012 2032 2044
6. P.E. Cramer, J.R. Cirrito, and D.W. Wesson ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models Science Express/ www.scienceexpress.org / 9 February 2012/ Page 1/10.1126/science. 1217697
7. K.G. Mawuenyega, W. Sigurdson, and V. Ovod Decreased clearance of CNS beta-amyloid in Alzheimer's disease Science 330 6012 2010 1774 [Epub 2010 Dec 9]
8. S. Gandy, and S.T. DeKosky APOE ε4 status and traumatic brain injury on the gridiron or the battlefield Sci Transl Med 4 134 2012 134ed4
9. M.R. Subuncu, R.S. Desikan, and J. Sepulcre The dynamics of cortical and hippocampal atrophy in Alzheimer disease Arch Neurol 68 2011 1040 1048
10. B.C. Dickerson, T.R. Stoub, and R.C. Shah Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults Neurology 76 2011 1395 1402
11. M. Tondelli, G.K. Wilcock, and P. Nichelli Structural MRI changes detectable up to ten years before clinical Alzheimer's disease Neurobiol Aging 33 2012 825.e25 825.e36
12. E. Westman, L. Cavallin, and J.S. Muehlboeck Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease PloS ONE 6 7 2011 e22506 [Epub 2011 July 21.]
13. C. Fennema-Notestine, M.S. Panizzon, and W.R. Thompson Presence of ApoE ε4 allele associated with thinner frontal cortex in middle age J Alzheimers Dis 26 Suppl. 3 2011 49 60
14. V. Berti, L. Mosconi, and L. Glodzik Structural brain changes in normal individuals with a maternal history of Alzheimer's Neurobiol Aging 32 12 2011 2325.e17 2325.e26
15. L. Mosconi Brain glucose metabolism in the early and specific diagnosis of Alzhiemer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32 2005 486 510
16. K. Talbot, H.-Y. Wang, and H. Kazi Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline J Clin Invest 122 2012 1316 1338
17. Y. Liu, F. Liu, K. Iqbal, I. Grundke-Iqbal, and C.-X. Gong Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease FEBS Lett 582 2008 359 364
18. L. Mosconi, V. Berti, and P. McHugh A tale of two tracers: glucose metabolism and amyloid positron emission tomography imaging in Alzheimer's disease J.W. Ashford, Handbook of imaging the Alzheimer brain 2011 IOS Press 219 234
19. M.J. de Leon, A. Convit, and O.T. Wolf Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose/positron- emission tomography (FDG/PET) Proc Natl Acad Sci USA 98 2001 10966 10971
20. L. Mosconi Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism Proc Natl Acad Sci USA 104 2007 19067 19072
21. A.G. Vlassenko, M.A. Mintun, and C. Xiong Amyloid-beta plaque growth in cognitively normal adults: longitudinal [11C]Pittsburgh compound B data Ann Neurol 70 2011 857 861
22. A.S. Fleisher, K. Chen, and X. Liu Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease Arch Neurol 68 2011 1404 1411
23. A.S. Fleisher, K. Chen, and X. Liu Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease Neurobiol Aging 2012 [in press]
24. Z. Wu, C. Kinslow, K.D. Pettigrew, S.I. Rapoport, and M.B. Schapiro Role of familial factors in late-onset Alzheimer disease as a function of age Alzheimer Dis Assoc Disord 12 1998 190 197
25. C. Xiong, C.M. Roe, and V. Buckles Role of family history for Alzheimer biomarker abnormalities in the adult children study Arch Neurol 68 2011 1313 1319
26. C.H. Sadowsky, and J.E. Galvin Guidelines for the management of cognitive and behavioral problems in dementia J Am Board Fam Med 25 2012 350 366
27. L.J. Martin Biology of mitochondria in neurodegenerative diseases Prog Mol Biol Transl Sci 107 2012 355 415
28. S.H. Lee, K.R. Kim, and S.Y. Ryu Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease J Neurosci 32 2012 5953 5963
29. M. Varghese, W. Zhao, and J. Wang Mitochondrial bioenergetics is defective in presymptomatic Tg2576 AD mice Transl Neurosci 2 2011 1 5
30. J. Yao, R.W. Irwin, L. Zhao, J. Nilsen, R.T. Hamilton, and R.D. Brinton Mitochondrial bioenergetics deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease Proc Natl Acad Sci USA 106 2009 14670 14675
31. J. Valla, R. Yaari, and A.B. Wolf Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE ε4 allele, the major late-onset Alzheimer's susceptibility gene J Alzheimers Dis 22 2010 307 313
32. J. Fan, J. Donkin, and C. Wellington Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E Biofactors 35 2009 239 248
33. R.L. Veech, C.R. Valenti, and T.B. VanItallie The mitochondrial permeability transition pore provides a key to the diagnosis and treatment of traumatic brain injury IUBMB Life 64 2012 203 207